Investors

Iren decides on the dismissal of Dr. Paolo Signorini for just objective cause

25 Jun 2024

The Board of Directors of Iren SpA, in today's meeting, taking into account the investigation conducted both by the Remuneration and Appointments Committee (also in its capacity as Committee for Related Party Transactions) and by the Control, Risk and Sustainability Committee, resolved the dismissal of Dr. Paolo Signorini for objective just cause, as a consequence of the objective incompatibility of the doctor's work performance. Signorini, in his capacity as Top Manager of Iren SpA, with the contingent situation that has arisen.

 

The precautionary custody measures taken against Dr. Signorini on 7 May 2024, connected to the ongoing investigations of the Public Prosecutor's Office of Genoa and confirmed even after the requests made by his defense, cause an impossibility, now irreversible and no longer just temporary, of exercising his functions as Top Manager. As regards the economic elements, the disbursement of sums of money in relation to the termination of the fixed-term employment relationship before the expiry of the term is not envisaged. Furthermore, all the instruments for protecting the rights and prerogatives of the Company remain intact, as they have already been reminded to the market and shareholders in the specific supplementary report pursuant to art. 125-quater TUF approved by the Board of Directors of the Company on 30 May 2024.

 

The Board of Directors confirmed the current organizational configuration approved in the extraordinary meeting of 7 May: the group is directed and coordinated by the Executive President and the Executive Vice President, to whom the delegations and powers previously assigned to the former CEO have been attributed.

 

The Dr. Signorini does not appear to hold Iren shares.

Download the complete Press Release

Download the complete Press Release

View

Download